A Study to Evaluate the Activity, and Safety of Vixarelimab in Participants With Moderate to Severe Active Ulcerative Colitis
Clinical trial NCT06693908 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06693908
- Sponsor
- Genentech, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-31
- Primary completion
- 2026-07-13
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.